Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, TDS, FVT

Neurocrine Biosciences to Present at the Bank of America Securities 2020 Napa Biopharma Conference


SAN DIEGO, June 15, 2020 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Bank of America Securities 2020 Napa Biopharma Conference at 2:00 p.m. PT (5:00 p.m. ET) on Monday, June 22, 2020. Kevin Gorman, Chief Executive Officer, will present at the conference.

The live presentation will be webcast and may be accessed on the Company's website under Investors at www.neurocrine.com. A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for approximately one month.

About Neurocrine Biosciences
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with 28 years of experience discovering and developing life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis* and uterine fibroids*, and clinical development programs in multiple therapeutic areas including a gene therapy for Parkinson's disease, chorea in Huntington disease, congenital adrenal hyperplasia, epilepsy, and polycystic ovary syndrome*. Headquartered in San Diego, Neurocrine Biosciences specializes in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. For more information, visit neurocrine.com, and follow the company on LinkedIn. (*in collaboration with AbbVie)

SOURCE Neurocrine Biosciences, Inc.


These press releases may also interest you

at 14:29
iHealth Unveils Breakthrough 3-in-1 At-Home 15-Minute Antigen Test for COVID-19 and Flu A&B
iHealth Labs, Inc. (iHealth®), a leading provider of digital health solutions, today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the company's 3-in-1 COVID-19/Flu A&B Rapid Test Kit...

at 14:24
Bulletproof Recognized as a Microsoft Security Excellence Awards Winner for Security Trailblazer
Bulletproof today announced it won the Security Trailblazer award in the Microsoft Security Excellence Awards 2024. The company's innovation and achievements over the past 12 months have elevated and distinguished it within the Microsoft Intelligent...

at 14:20
Abel Communications Launches New On-Demand Thought Leadership Program
Abel Communications, an award-winning public relations firm, has announced the launch of "Expertise, Amplified," an on-demand Thought Leadership program designed to programmatically and strategically raise the profile of subject matter experts....

at 14:15
Genesis Unveils Emerging Technology, HOCl Atomizing, for 'Air Quality Awareness Week'
Frederick, MD-based Genesis + HOCL introduces two HOCl atomizing machines for Air Quality Awareness Week. Genesis is the sole U.S. distributor of this technology, previously only available in Japan and South Korea, bringing the Genesis 2.6 and UX4 to...

at 14:09
Federal government partners with Indigenous Peoples in Timiskaming District
The federal government is investing in green and inclusive retrofits for Indigenous education facilities in Kirkland Lake and Temiskaming Shores to convert land in Kirkland Lake into a food forest. Announced by MP Anthony Rota and Bertha Cormier,...

at 14:05
Avicenna Introduces Machine Learning-Enhanced Medicinal Chemistry Platform to Accelerate the Last Mile of Small Molecule Drug Discovery
Avicenna Biosciences today introduced an extension to its machine learning (ML) technology platform to enhance medicinal chemistry and expedite clinical-stage drug discovery. The company has raised $14.5 million in funding to date, with DCVC Bio...

More news about Science and technology...


News published on and distributed by: